49 results on '"Kastelein J"'
Search Results
2. Abstract: 1447 ALTERNATIVE LIPID MODIFYING STRATEGIES
3. Abstract: P423 AN INFLAMMATORY STATE AS OBSERVED IN PATIENTS WITH SEPSIS AND CROHN'S DISEASE DOES NOT AFFECT ABCA-1 MEDIATED CHOLESTEROL EFFLUX
4. Abstract: 552 HUMAN TRIGLYCERIDE METABOLISM: NEW PROTEINS, NEW INSIGHTS
5. 4P-1212 The ENHANCE trial: Ezetimibe and simvastatin in hypercholesterolemia enhances atherosclerosis regression
6. 0SOA01-2 IMT, CRP and atherosclerosis
7. HIGH-DOSE ATORVASTATIN ATTENUATES CARDIOVASCULAR RISK PREDICTION OF THE METABOLIC SYNDROME COMPONENTS: THE TREATING TO NEW TARGETS STUDY
8. Abstract: P365 LOSS OF DISULFIDE BOND IN LECITHIN:CHOLESTEROL ACYL TRANSFERASE DUE TO A CYS313—>TYR MUTATION CAUSES FAMILIAL LCAT DEFICIENCY IN A PATIENT OF MOROCCAN DESCENT
9. M.681 Clinical relevance of identification of exercise-induced hypertension in adults who received surgical correction of aortic coarctation in childhood
10. Can monogenic severe hypertriglyceridemia be differentiated from polygenic forms through clinical features: data from approach and compass studies in fcs and non-fcs hypertriglyceridemic patients?.
11. LDL CHOLESTEROL GOAL ATTAINMENTS IN THE IDEAL STUDY
12. M.501 M-mode ultrasound imaging of arterial wall movement and arterial wall thickness of distal carotid arteries in atherosclerosis studies in healthy adults
13. W14.396 The effects of paraoxonase on cholesterol lowering by simvastatin and atorvastatin
14. MS359 DAL-VESSEL – A RANDOMISED, PLACEBO-CONTROLLED STUDY OF DALCETRAPIB ON ENDOTHELIAL FUNCTION, AS MEASURED BY FLOW MEDIATED DILATATION, IN HIGH-RISK PATIENTS
15. P178 CORONARY PATIENTS REACHING LDL-CHOLESTEROL < 2.0 mmol/L HAVE THE LOWEST RISK OF CARDIOVASCULAR EVENTS DURING STATIN TREATMENT: THE IDEAL STUDY
16. Abstract: S3-21 FINDING NOVEL HDL GENES
17. Abstract: P841 NON-FUNCTIONALITY OF THREE LDL-R AND APOB GENE MUTATIONS THAT WERE ASSUMED TO CAUSE FAMILIAL HYPERCHOLESTEROLEMIA
18. Abstract: P810 PROLACTIN LEVELS AND THE RISK OF FUTURE CORONARY ARTERY DISEASE IN APPARENTLY HEALTHY MEN AND WOMEN. A PROSPECTIVE CASE-CONTROL STUDY NESTED IN THE EPICNORFOLK COHORT
19. Abstract: P895 GENETIC VARIANTS IN PHOSPHOLIPID TRANSFER PROTEIN (PLTP) AFFECT PLTP ACIVITY, HIGH-DENSITY LIPOPROTEIN SIZE AND RISK OF CORONARY ARTERY DISEASE
20. Abstract: P863 FUNCTIONAL DEFECTS IN LDL-RECEPTOR DO NOT LIMIT ACUTE CORTISOL RESPONSE
21. Abstract: P870 IDENTIFICATION OF APOB AND PCSK9 MUTATIONS CAUSING A NON-ADH PHENOTYPE IN MOLECULAR DIAGNOSED ADH PATIENTS
22. Abstract: P475 SAFETY AND EFFICACY OF AMT-010 GENE THERAPY IN LIPOPROTEIN LIPASE DEFICIENCY (LPLD)
23. Abstract: P378 EFFECTS OF LONG-TERM LDL-C LOWERING ON ATHEROSCLEROSIS IN ADULTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
24. Abstract: P213 DIFFERENTIAL MONOCYTIC GENE EXPRESSION IN SUBJECTS WITH PREMATURE MYOCARDIAL INFARCTION
25. Abstract: 1090 POTENTIAL ROLE FOR INSULIN IN SPROUTING OF NEOVESSELS WITHIN ATHEROSCLEROTIC PLAQUES; NEW PATHWAYS OF MICROVASCULAR COMPLICATIONS IN MACROVASCULAR DISEASE OF DIABETES
26. Abstract: 1024 THE DYSLIPIDEMIA OF MOTHERS WITH FAMILIAL HYPERCHOLESTEROLEMIA DETERIORATES LIPID LEVELS IN THEIR ADULT OFFSPRING
27. Abstract: 608 WALL SHEAR STRESS CORRELATES WITH THE ELASTICITY AND THICKNESS OF THE CAROTID ARTERY WALL: A 3.0 TESLA MRI STUDY
28. Abstract: 576 LIPID-LOWERING MEDICATION TWO YEARS AFTER MOLECULAR DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
29. Abstract: 580 BASELINE CHOLESTEROL SYNTHESIS MARKERS DO NOT PREDICT SIMVASTATIN-INDUCED LDL-CHOLESTEROL REDUCTION OR CHANGE IN CAROTID INTIMA MEDIA THICKNESS IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; A POST-HOC ANALYSIS OF THE ENHANCE TRIAL
30. Abstract: 577 COLESEVELAM ADDED TO STABLE COMBINATION OF STATIN AND EZETIMIBE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; THE TRIPLE TRIAL
31. Abstract: P242 PROLACTIN DOES NOT AFFECT HUMAN PLATELET AGGREGATION OR SECRETION
32. Abstract: 536 BASELINE CHOLESTEROL ABSORPTION MARKERS DO NOT PREDICT LDL-CHOLESTEROL REDUCTION BY EZETIMIBE/SIMVASTATIN IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; A POST-HOC ANALYSIS OF THE ENHANCE TRIAL
33. Abstract: 141 TWO MUTATIONS IN GPIHBP1 CAUSE SEVERE CHYLOMICRONEMIA AND PROVIDE EVIDENCE FOR A CRITICAL ROLE OF GPIHBP1 IN HUMAN TRIGLYCERIDE METABOLISM
34. Abstract: 104 EFFECT OF MIPOMERSEN TREATMENT ON HEPATIC TRIGLYCERIDE CONTENT IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
35. Abstract: 48 PHENOTYPE AND GENOTYPE OF FAMILIAL HYPERCHOLESTEROLEMIA IN OVER 2000 CHILDREN
36. Abstract: 541 IMAGING CAROTID ATHEROSCLEROSIS
37. STATINS AND RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY REVASCULARIZATION (CR) IN THE IDEAL TRIAL
38. EZETIMIBE COADMINISTERED WITH SIMVASTATIN IN ADOLESCENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
39. IMPORTANCE OF TRIGLYCERIDES IN PATIENTS AT LDL-C GOAL: ANALYSIS OF INCREMENTAL DECREASE IN ENDPONTS THROUGH AGGRESSIVE LIPID LOWERING (IDEAL) TRIAL
40. EFFECT OF DIFFERENTIAL TREATMENT ADHERENCE IN RECENT MI PATIENTS IN THE IDEAL TRIAL
41. COMPOSITIONAL PROTEIN PROFILING OF HDL BY SELDI-TOF MS DURING EXPERIMENTAL ENDOTOXEMIA
42. Th-P15:183 Low high-density lipoprotein cholesterol predisposes to increased inflammatory and coagulation responses upon endotoxin infusion in vivo
43. We-P11:84 The infusion of C-reactive protein adversely affects glucose metabolism in humans
44. We-W32:3 Infusion of C-reactive protein mediates activation of circulating leukocytes in humans
45. Mo-P6:420 Two novel APOA5 missense mutations in patients with severe hypertriglyceridemia
46. M.475 Repeatability of brachial FMD measurements in healthy adults and power calculation for studies
47. W08.194 Polymorphisms in SREBP-2 and SCAP may be associated with plasma lipid levels in familial hypercholesterolemia
48. 2P-0563 Variants of the toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events
49. 2P-0452 A genetic, biochemical and proteomic approach to dissection of inherited HDL phenotypes in humans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.